Jonlim Samba "It's not easy management, you'll see the result as one team."
Jonlim Samba "It's not easy management, you'll see the result as one team."
  • Cho Pil Hyun, Staff Reporter
  • 승인 2024.03.19 14:06
  • 수정 2024.03.19 14:06
  • 댓글 0
이 기사를 공유합니다

Samsung Biologics (Samba) held its 13th regular shareholders' meeting at Songdo Convensia in Incheon on the 15th.

Samba explained that it will accelerate its strategy to expand its three pillars (production capacity, business portfolio, and geographic base) and strengthen the value of '4E' such as customer satisfaction, operational efficiency, highest quality, and employee capabilities.

The construction of the Songdo 5 plant, which is under construction with the aim of completing in April next year, is underway without a hitch, and it added that it will secure competitiveness in the ADC field through an antibody-drug conjugate (ADC) dedicated production facility scheduled to be completed in December.

Seo Seung-hwan, an honorary professor at Yonsei University, was newly appointed as an outside director and audit committee member.

This year, the remuneration limit for directors was frozen at 15 billion won, and 9.35 billion won out of the 15 billion won limit for directors was actually executed last year.

"It is expected that the difficult business environment will continue this year, but we will not stop challenging global top tier companies," Samba President Jonlim said. "All executives and employees will work together as one team to show the best results."

[WIKI KOREA=Cho Pil Hyun, Staff Reporter]

기자가 쓴 기사

  • 서울특별시 마포구 마포대로 127, 1001호 (공덕동, 풍림빌딩)
  • 대표전화 : 02-702-2677
  • 팩스 : 02-702-1677
  • 청소년보호책임자 : 소정원
  • 법인명 : 위키리크스한국 주식회사
  • 제호 : 위키리크스한국
  • 등록번호 : 서울 아 04701
  • 등록일 : 2013-07-18
  • 발행일 : 2013-07-18
  • 발행인 : 박정규
  • 편집인 : 박찬흥
  • 위키리크스한국은 자체 기사윤리 심의 전문위원제를 운영합니다.
  • 기사윤리 심의 : 박지훈 변호사
  • 위키리크스한국 모든 콘텐츠(영상,기사, 사진)는 저작권법의 보호를 받은바, 무단 전재와 복사, 배포 등을 금합니다.
  • Copyright © 2024 위키리크스한국. All rights reserved.
  • [위키리크스한국 보도원칙] 본 매체는 독자와 취재원 등 뉴스 이용자의 권리 보장을 위해 반론이나 정정보도, 추후보도를 요청할 수 있는 창구를 열어두고 있음을 알립니다.
    고충처리 : 02-702-2677 | 메일 :